Growth Metrics

Regeneron Pharmaceuticals (REGN) EPS (Basic) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.78%
Dec 31, 2025 -3.51%
Sep 30, 2025 13.63%
Jun 30, 2025 -0.08%
Mar 31, 2025 13.13%
Dec 31, 2024 -21.58%
Sep 30, 2024 30.80%
Jun 30, 2024 46.41%
Mar 31, 2024 -12.30%
Dec 31, 2023 -2.85%
Sep 30, 2023 -22.99%
Jun 30, 2023 14.56%
Mar 31, 2023 -16.23%
Dec 31, 2022 -46.57%
Sep 30, 2022 -19.91%
Jun 30, 2022 -73.23%
Mar 31, 2022 -13.80%
Dec 31, 2021 92.48%
Sep 30, 2021 92.61%
Jun 30, 2021 260.32%
Mar 31, 2021 85.94%
Dec 31, 2020 50.34%
Sep 30, 2020 30.39%
Jun 30, 2020 362.71%
Mar 31, 2020 34.52%
Dec 31, 2019 -4.35%
Sep 30, 2019 11.27%
Jun 30, 2019 -65.43%
Mar 31, 2019 -4.73%
Dec 31, 2018 367.90%
Sep 30, 2018 51.10%
Jun 30, 2018 39.89%
Mar 31, 2018 88.14%
Dec 31, 2017 -32.78%
Sep 30, 2017 43.87%
Jun 30, 2017 94.68%
Mar 31, 2017 35.63%
Dec 31, 2016 61.74%
Sep 30, 2016 24.02%
Jun 30, 2016 -0.53%
Mar 31, 2016 135.14%
Dec 31, 2015 67.42%
Sep 30, 2015 145.78%
Jun 30, 2015 96.88%
Mar 31, 2015 7.25%
Dec 31, 2014 -9.18%
Sep 30, 2014 -42.36%
Jun 30, 2014 7.87%
Mar 31, 2014 -32.35%
Dec 31, 2013 -80.08%
Sep 30, 2013 -28.71%
Jun 30, 2013 9.88%
Mar 31, 2013 750.00%
Dec 31, 2012 948.28%
Sep 30, 2012 397.06%
Jun 30, 2012 217.39%
Mar 31, 2012 124.49%
Dec 31, 2011 -241.18%
Sep 30, 2011 -65.85%
Jun 30, 2011 -122.58%
Mar 31, 2011 -28.95%
Dec 31, 2010 66.60%
Sep 30, 2010 96.78%
Jun 30, 2010 99.83%